Sensus Healthcare, Inc. (SRTS) Surpasses Market Returns: Some Facts Worth Knowing

Company Overview - Sensus Healthcare, Inc. (SRTS) experienced a stock increase of +2.26% to $3.17, outperforming the S&P 500's daily gain of 0.26% [1] - However, the stock has declined by 8.55% over the past month, underperforming the Medical sector's loss of 0.57% and the S&P 500's gain of 2.87% [1] Upcoming Earnings - The upcoming earnings release is anticipated to show an EPS of -$0.12, representing a significant decline of 271.43% from the same quarter last year [2] - Revenue is expected to be $4.64 million, indicating a 47.51% decrease compared to the prior year's corresponding quarter [2] Fiscal Year Estimates - For the entire fiscal year, the Zacks Consensus Estimates predict an EPS of -$0.43 and revenue of $26.34 million, reflecting changes of -204.88% and -37% respectively from the previous year [3] Analyst Estimates - Recent adjustments to analyst estimates for Sensus Healthcare are crucial as they reflect the changing dynamics of short-term business patterns [4] - Positive revisions in estimates indicate analysts' confidence in the company's performance and profit potential [4] Zacks Rank System - The Zacks Rank system, which ranges from 1 (Strong Buy) to 5 (Strong Sell), has a proven track record of outperforming, with stocks rated 1 yielding an average annual return of +25% since 1988 [6] - Currently, Sensus Healthcare holds a Zacks Rank of 5 (Strong Sell), with the consensus EPS estimate having decreased by 62.26% over the last 30 days [6] Industry Context - Sensus Healthcare operates within the Medical - Instruments industry, which has a Zacks Industry Rank of 90, placing it in the top 37% of over 250 industries [7] - The performance of individual industry groups is measured by the Zacks Industry Rank, with top-rated industries outperforming the bottom half by a factor of 2 to 1 [7]